Reverse transcriptase inhibitors in Aicardi‐Goutières syndrome: A crossover clinical trial

Publication Details

Journal
Developmental Medicine & Child Neurology
Published
2024-12-22
DOI
https://doi.org/10.1111/dmcn.16222
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reverse transcriptase inhibitors in Aicardi‐Goutières syndrome: A crossover clinical trial

Developmental Medicine & Child Neurology
interferon and immune responses
article

Reverse transcriptase inhibitors in Aicardi‐Goutières syndrome: A crossover clinical trial

article en

Abstract

No abstract available for this paper.
Developmental Medicine & Child NeurologyVol. 67(2)
Openalex Percentile: Top 70%
interferon and immune responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Reverse transcriptase inhibitors in Aicardi‐Goutières syndrome: A crossover clinical trial · Developmental Medicine & Child Neurology (2024) | TGRS Research Map | TGRS